2025 ICD-10-CM Procedure Code 3E0607Z

Introduction of Electrolytic and Water Balance Substance into Central Artery, Open Approach

ICD-10-PCS Code:: 3E0607Z
ICD-10-PCS Code for:: Introduce Electrol/Water Bal in Central Art, Open
Is Billable?: Yes - Valid for Submission
Code Navigator:

3E0607Z is a billable procedure code used to specify the performance of introduction of electrolytic and water balance substance into central artery, open approach. The code is valid for the year 2025 for the submission of HIPAA-covered transactions.

Table of Contents

Code Information
PCS Table
Other Similar Codes

3E0607Z PCS Table

In an PCS table each code is represented by up seven alphanumeric characters, with each character in the table respresenting different aspects of the procedure. In the table provided below, each row represents an individual character and includes information about the character's position, designation, label, and procedure notes. For this PCS table the procedure code is in the administration section and is part of the physiological systems and anatomical regions body system, classified under introduction operation. The applicable bodysystem/region for this procedure code is central artery.

Position	Designation	Character	Label	Procedures Notes
1	Section	3	Administration
2	Body System	E	Physiological Systems and Anatomical Regions
3	Operation	0	Introduction
4	BodySystem/Region	6	Central Artery
5	Approach	0	Open
6	Substance	7	Electrolytic and Water Balance Substance
7	Qualifier	Z	No Qualifier	Explanation: The value Z is used for the seventh character to indicate that a specific qualifier does not apply to the procedure.

Other ICD-10-PCS Codes Used for Introduction Central Artery

Filter related codes list:

3E06002 Introduction of High-dose Interleukin-2 into Central Artery, Open Approach
3E06003 Introduction of Low-dose Interleukin-2 into Central Artery, Open Approach
3E06005 Introduction of Other Antineoplastic into Central Artery, Open Approach
3E0600M Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach
3E0600P Introduction of Clofarabine into Central Artery, Open Approach
3E06016 Introduction of Recombinant Human-activated Protein C into Central Artery, Open
3E06017 Introduction of Other Thrombolytic into Central Artery, Open Approach
3E06028 Introduction of Oxazolidinones into Central Artery, Open Approach
3E06029 Introduction of Other Anti-infective into Central Artery, Open Approach
3E0603Z Introduction of Anti-inflammatory into Central Artery, Open Approach
3E0604Z Introduction of Serum, Toxoid and Vaccine into Central Artery, Open Approach
3E0606Z Introduction of Nutritional Substance into Central Artery, Open Approach
3E060FZ Introduction of Intracirculatory Anesthetic into Central Artery, Open Approach
3E060GC Introduction of Other Therapeutic Substance into Central Artery, Open Approach
3E060GN Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Open Approach
3E060HZ Introduction of Radioactive Substance into Central Artery, Open Approach
3E060KZ Introduction of Other Diagnostic Substance into Central Artery, Open Approach
3E060NZ Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Open Approach
3E060PZ Introduction of Platelet Inhibitor into Central Artery, Open Approach
3E060RZ Introduction of Antiarrhythmic into Central Artery, Open Approach
3E060TZ Introduction of Destructive Agent into Central Artery, Open Approach
3E060VG Introduction of Insulin into Central Artery, Open Approach
3E060VH Introduction of Human B-type Natriuretic Peptide into Central Artery, Open Approach
3E060VJ Introduction of Other Hormone into Central Artery, Open Approach
3E060WK Introduction of Immunostimulator into Central Artery, Open
3E060WL Introduction of Immunosuppressive into Central Artery, Open
3E060XZ Introduction of Vasopressor into Central Artery, Open Approach
3E06302 Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach
3E06303 Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach
3E06305 Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach
3E0630M Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach
3E0630P Introduction of Clofarabine into Central Artery, Percutaneous Approach
3E06316 Introduction of Recombinant Human-activated Protein C into Central Artery, Percutaneous
3E06317 Introduction of Other Thrombolytic into Central Artery, Percutaneous Approach
3E06328 Introduction of Oxazolidinones into Central Artery, Percutaneous Approach
3E06329 Introduction of Other Anti-infective into Central Artery, Percutaneous Approach
3E0633Z Introduction of Anti-inflammatory into Central Artery, Percutaneous Approach
3E0634Z Introduction of Serum, Toxoid and Vaccine into Central Artery, Percutaneous Approach
3E0636Z Introduction of Nutritional Substance into Central Artery, Percutaneous Approach
3E0637Z Introduction of Electrolytic and Water Balance Substance into Central Artery, Percutaneous Approach
3E063FZ Introduction of Intracirculatory Anesthetic into Central Artery, Percutaneous Approach
3E063GC Introduction of Other Therapeutic Substance into Central Artery, Percutaneous Approach
3E063GN Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Percutaneous Approach
3E063HZ Introduction of Radioactive Substance into Central Artery, Percutaneous Approach
3E063KZ Introduction of Other Diagnostic Substance into Central Artery, Percutaneous Approach
3E063NZ Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Percutaneous Approach
3E063PZ Introduction of Platelet Inhibitor into Central Artery, Percutaneous Approach
3E063RZ Introduction of Antiarrhythmic into Central Artery, Percutaneous Approach
3E063TZ Introduction of Destructive Agent into Central Artery, Percutaneous Approach
3E063VG Introduction of Insulin into Central Artery, Percutaneous Approach
3E063VH Introduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach
3E063VJ Introduction of Other Hormone into Central Artery, Percutaneous Approach
3E063WK Introduction of Immunostimulator into Central Artery, Percutaneous
3E063WL Introduction of Immunosuppressive into Central Artery, Percutaneous
3E063XZ Introduction of Vasopressor into Central Artery, Percutaneous Approach

What is ICD-10-PCS?

The ICD-10 Procedure Coding System (ICD-10-PCS) is a catalog of procedural codes used by medical professionals for hospital inpatient healthcare settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates. The 2025 ICD-10-PCS codes are to be used for discharges occurring from October 1, 2024 through September 30, 2025.

Each ICD-10-PCS code has a structure of seven alphanumeric characters and contains no decimals. The first character defines the major "section". Depending on the "section" the second through seventh characters mean different things.